Quipt Home Medical Corp T.QIPT

Conf call

[lscfa]

 

 

GLP-1 drugs have had no impact on sleep sales

 

Resmed also says no impact

 

Over 20 million Americans with sleep apnea have not been diagnosed yet

 

3% increase to reimbursement rates beginning Jan 01/24

 

< 5% of prescriptions from e-prescribing, room for efficiencies

 

Avg resupply patient spends $600/yr and increasing

 

Run rate on resupply orders $100 million/yr (169,000 patients)

 

Avg. resupply patient duration is 4 to 5 yrs.

 

Resupply biz ~ 40-50% of respiratory revenues

 

Resupply gross margins ~42%

 

Resupply is low touch biz, orders by email or app

 

Resupply ebitda > rental biz

 

Q4 organic growth 3.5%, above 8-10% annual target

 

At 90 sales people real time, up from 72 last Conf call

 

Sales people need 2 to 3 qtrs to ramp up

 

negotiations ongoing for additional insurance contracts

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

[checkup]

When might the bottom line be positive?  

[ramman1]

When they complete the asset rationlization plan, ( sell off some non-performing assets). They just wont be asked your question , and consequently not hear that answer . But it will happen and bottom line profit will ensue.

[Carlito3311]

This post has been removed in accordance with Community Policy

[lscfa]

As we move into fiscal 2024, we continue to see improving net cash flow from operations. On our last conference call, we increased our guidance to 6% to 8% net cash from operations after CapEx and or lease payments, and before any debt service and purchase price payable related payments. We are very confident in our ability to continue to grow our net cash flow inclusive of our CapEx needs and